-
Capricor Therapeutics (CAPR) Announces Common Stock Offering
-
Capricor Therapeutics Announces Proposed Public Offering of Common Stock
-
Roth Capital Remains Bullish on Capricor Therapeutics (CAPR) Following Strong CAP-1002 Data in AHF
-
Roth Capital Starts Capricor Therapeutics (CAPR) at Buy
-
Capricor Therapeutics Announces $4 Million Registered Direct Offering

